Sale!

EARS2 Gene Combined oxidative phosphorylation deficiency type 12 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The EARS2 gene is associated with combined oxidative phosphorylation deficiency type 12, a rare genetic disorder that affects mitochondrial function, leading to a range of symptoms including developmental delay, muscle weakness, and neurological problems. Testing for mutations in the EARS2 gene can be crucial for diagnosing this condition, guiding treatment options, and providing information on the genetic risk for family members.

At DNA Labs UAE, a genetic test is available for identifying mutations in the EARS2 gene. The cost of the test is 4400 AED. This test involves analyzing the patient’s DNA to look for specific mutations in the EARS2 gene that are known to cause combined oxidative phosphorylation deficiency type 12. The process is conducted in a state-of-the-art laboratory setting by experienced geneticists and technicians, ensuring accurate and reliable results.

The test is recommended for individuals who exhibit symptoms suggestive of mitochondrial disorders or have a family history of such conditions. Early detection through genetic testing can be instrumental in managing the condition more effectively and improving the quality of life for those affected.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

EARS2 Gene Combined Oxidative Phosphorylation Deficiency Type 12 Genetic Test

Test Details

The EARS2 gene is associated with a condition called Combined Oxidative Phosphorylation Deficiency Type 12 (COXPD12). This condition is characterized by a deficiency in the production of adenosine triphosphate (ATP), which is the main source of energy for cells.

NGS Genetic Testing refers to Next-Generation Sequencing, a high-throughput DNA sequencing technology that allows for the rapid and efficient sequencing of large amounts of genetic material. In the context of COXPD12, NGS Genetic Testing can be used to analyze the EARS2 gene and identify any genetic variations or mutations that may be causing the condition.

By identifying specific genetic variations or mutations in the EARS2 gene, NGS Genetic Testing can help diagnose COXPD12 and provide important information about the underlying cause of the condition. This information can be used to guide treatment decisions, provide prognostic information, and inform genetic counseling for affected individuals and their families.

Test Name: EARS2 Gene Combined Oxidative Phosphorylation Deficiency Type 12 Genetic Test

Components:

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Metabolic Disorders
  • Doctor: General Physician
  • Test Department: Genetics

Pre Test Information

Clinical History of Patient who is going for EARS2 Gene Combined Oxidative Phosphorylation Deficiency Type 12 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Combined Oxidative Phosphorylation Deficiency Type 12.

Test Name EARS2 Gene Combined oxidative phosphorylation deficiency type 12 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Metabolic Disorders
Doctor General Physician
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for EARS2 Gene Combined oxidative phosphorylation deficiency type 12 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Combined oxidative phosphorylation deficiency type 12
Test Details

The EARS2 gene is associated with a condition called Combined Oxidative Phosphorylation Deficiency Type 12 (COXPD12). This condition is characterized by a deficiency in the production of adenosine triphosphate (ATP), which is the main source of energy for cells.

NGS Genetic Testing refers to Next-Generation Sequencing, a high-throughput DNA sequencing technology that allows for the rapid and efficient sequencing of large amounts of genetic material. In the context of COXPD12, NGS Genetic Testing can be used to analyze the EARS2 gene and identify any genetic variations or mutations that may be causing the condition.

By identifying specific genetic variations or mutations in the EARS2 gene, NGS Genetic Testing can help diagnose COXPD12 and provide important information about the underlying cause of the condition. This information can be used to guide treatment decisions, provide prognostic information, and inform genetic counseling for affected individuals and their families.